New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 28, 2014
05:11 EDTTEVA, TKPYYTeva, Takeda Pharmaceutical agree to commercialize rasagilinein Japan
Teva Pharmaceutical (TEVA) and Takeda Pharmaceutical (TKPYY) have signed an agreement allowing Takeda to commercialize Tevaís innovative treatment for Parkinsonís disease, rasagiline in Japan. Developed by Teva, rasagiline tablets are approved in over 40 countries for the treatment of Parkinsonís disease. Teva developed this product and received its first approval in 2005 in Israel and Europe, and is currently working towards the acquisition of marketing approval of this product in Japan. Under the terms of the agreement, Takeda will develop rasagiline tablets for the Japanese market and submit a New Drug Application for registration of the product in Japan. The financial details of the agreement are confidential.
News For TEVA;TKPYY From The Last 14 Days
Check below for free stories on TEVA;TKPYY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2014
09:06 EDTTKPYYTakeda unit granted orphan status for pancreatic cancer treatment
Millennium Pharmaceuticals' treatment of pancreatic cancer was granted FDA orphan designation, according to a post to the regulator's site. Reference Link
July 25, 2014
07:14 EDTTEVATeva August weekly volatility elevated into Q2 and outlook
Teva August weekly call option implied volatility is at 34, August is at 25, September and January is at 22; compared to its 26-week average of 27 according to Track Data, suggesting large near term price movement into the expected release of Q2 results on July 31.
July 24, 2014
07:27 EDTTEVASome of Teva's biggest investors to vote against re-electing directors, WSJ says
Subscribe for More Information
06:45 EDTTEVATeva price target raised to $70 from $65 at Barclays
Subscribe for More Information
July 23, 2014
10:02 EDTTEVAOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:10 EDTTEVADeutsche Bank hosts an analyst Specialty Pharma/Industry conference call
Subscribe for More Information
July 22, 2014
16:08 EDTTEVATeva initiated with a Buy at Deutsche Bank
Subscribe for More Information
July 21, 2014
15:10 EDTTKPYYTakeda Pharmaceutical unit granted orphan status for gastric cancer treatment
Subscribe for More Information
08:11 EDTTEVAArena Pharma' subsidiary enters into agreement for Belviq with Teva subsidiary
Subscribe for More Information
08:01 EDTTEVATeva completes acquisition of Labrys
Subscribe for More Information
July 16, 2014
08:48 EDTTEVATeva says ISS supports company's nominees, shareholders' meeting proposals
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use